Patrik Brundin (Former)
151 – 160 of 248
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2002
-
Mark
Effects of antioxidant pretreatment on the survival of embryonic dopaminergic neurons in vitro and following grafting in an animal model of Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Funding embryonic stem-cell research: will commerce counteract collaboration?
(
- Contribution to journal › Letter
-
Mark
Maintenance of susceptibility to neurodegeneration following intrastriatal injections of quinolinic acid in a new transgenic mouse model of Huntington's disease.
(
- Contribution to journal › Article
-
Mark
Increased Sensitivity to N-Methyl-D-Aspartate Receptor-Mediated Excitotoxicity in a Mouse Model of Huntington's Disease.
(
- Contribution to journal › Article
-
Mark
GDNF treatment in Parkinson's disease: time for controlled clinical trials?
(
- Contribution to journal › Letter
-
Mark
Huntington's disease: the mystery unfolds?
(
- Contribution to journal › Scientific review
-
Mark
Impaired dopamine storage resulting from alpha-synuclein mutations may contribute to the pathogenesis of Parkinson's disease.
(
- Contribution to journal › Scientific review
-
Mark
Comparison between survival of lazaroid-treated embryonic nigral neurons in cell suspensions, cultures and transplants.
(
- Contribution to journal › Article
-
Mark
Stem cells: hype or hope?
(
- Contribution to journal › Scientific review
-
Mark
Effect of mutant alpha-synuclein on dopamine homeostasis in a new human mesencephalic cell line.
(
- Contribution to journal › Article